Opioid Use Disorder
📧 Sign up to get email alerts when something new happens for Opioid Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Long-acting Naltrexone for Pre-release Prisoners [Phase 3]
A Phase 3 trial of long-acting naltrexone for opioid use disorder in pre-release prisoners has completed.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits [Phase 3]
Phase 3 trial update assessing mindfulness and chronic pain management visits to optimize care for chronic pain and prescription opioid misu…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Buprenorphine for Individuals in Jail [Phase 3]
A Phase 3 clinical trial evaluating buprenorphine for opioid use disorder in incarcerated individuals is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Divided or Single Exposure (DOSE) Study [Phase 2, Phase 3]
This ClinicalTrials.gov entry notes that the DOSE study, a Phase 2/Phase 3 trial sponsored by the University of Maryland, Baltimore, is curr…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Targeting Treatment-Resistant OUD With Ketamine-Assisted Mindfulness Oriented Recovery Enhancement [Phase 2]
A Phase 2 clinical trial update examining ketamine-assisted mindfulness-oriented recovery enhancement for treatment-resistant opioid use dis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment [Phase 3]
A Phase 3 clinical trial evaluating buprenorphine to bridge probationers and parolees with opioid use disorder into treatment has been suspe…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Pain Care at Home to Amplify Function (Pain CHAMP) [NA]
This entry reports a Yale University clinical trial (Pain CHAMP) that is active but not recruiting, investigating home-based pain care to im…
-
EMA approval · 2026-01-29EMA Authorised: Zubsolv (buprenorphine hydrochloride;naloxone hydrochloride dihydrate) — Accord Healthcare S.L.U.
The European Medicines Agency authorized Zubsolv, a fixed-dose buprenorphine/naloxone product, for opioid-related disorders; the marketing a…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Prevention Interventions for Opioid Misuse [NA]
The University of Michigan-sponsored trial update reports completed results for prevention interventions aimed at reducing opioid misuse.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Mobile Peer Support for OUD Recovery [NA]
Brown University is conducting a mobile peer support trial to assist recovery from Opioid Use Disorder. The study is currently active but no…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Digital Treatment for Chronic Pain and Addiction in Veterans With Opioid Use Disorder Receiving Buprenorphine [Phase 3]
This clinical trial update describes a Phase 3 study evaluating a digital treatment for chronic pain and opioid use disorder in veterans rec…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder [NA]
A NYU Langone Health-sponsored clinical trial is exploring regulatory-flexibility-enabled methadone take-home dosing to improve retention in…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Parenting Young Children Study [NA]
A completed clinical trial from the University of Oregon evaluating parenting interventions for families affected by opioid misuse and relat…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Adaptive Decision Support for Addiction Treatment (ADAPT) Factorial Trial [NA]
The Yale University-sponsored Adaptive Decision Support for Addiction Treatment (ADAPT) factorial trial evaluating decision support for Opio…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Mindfulness-Based Ecological Momentary Intervention for Opioid Use Disorder and Chronic Pain [NA]
A mindfulness-based ecological momentary intervention trial for chronic pain and opioid use disorder is currently recruiting at Arizona Stat…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail [Phase 2, Phase 3]
The document describes a Phase 2/3 clinical trial comparing extended-release naltrexone to extended-release buprenorphine for individuals le…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Cariprazine for Comorbid Cocaine and Opioid Use Disorder [Phase 2]
A Phase 2 study evaluating cariprazine for individuals with comorbid cocaine use disorder and opioid use disorder has completed.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Psilocybin for Opioid Use Disorder (OUD) [Phase 2]
A Phase 2 clinical trial is recruiting to evaluate psilocybin for Opioid Use Disorder.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: PRE-FAIR [NA]
This clinical trial, PRE-FAIR, evaluated strategies to prevent parental opioid and methamphetamine addiction in DHS-involved families and ha…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone Clinics [NA]
Completed clinical trial from Hanoi Medical University evaluating screening, treatment, and retention of methamphetamine users with opioid u…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Evaluating the Feasibility, Acceptability, and Preliminary Outcomes of Heart Rate Variability Biofeedback for Individuals With Opioid Use Disorder. [NA]
This clinical trial is evaluating the feasibility, acceptability, and preliminary outcomes of heart rate variability biofeedback for individ…
-
FDA approval · 2026-01-22FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for Methadone Hydrochloride submitted by VistaPharm, LLC.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Evaluating the SUBLOCADE Treatment Exit Strategy
This clinical trial update discusses the exit strategy for SUBLOCADE in treating Opioid Use Disorder. The study has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Opioid Adherence and Support Through Innovative Texting Strategies [NA]
This is a recruiting clinical trial from the University of New Mexico testing a text messaging–based adherence and support program for peopl…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Tau PET Imaging in Opioid Use Disorder [EARLY_Phase 1]
A Phase 1 clinical trial update investigating tau PET imaging in individuals with opioid use disorder is active but not recruiting.